MEDIA RELEASES

PHARMANIAGA, China's Suzhou Ronnsi Pharma Ink Partnership To Commercialise Malaysia's First Halal Blood Anti-Coagulant

15 JULY 2022

Pharmaniaga Berhad today has entered into a Memorandum of Collaboration with China’s Suzhou Ronnsi Pharma Co., Ltd to commercialise Halal ovine (sheep and goat) anti-coagulant    [see more]

PHARMANIAGA STRENGHTENS INDONESIAN MARKET PRESENCE, CONTINUES EXPANDING FOOTPRINT INTO GLOBAL POTENTIAL

13 JUNE 2022

Pharmaniaga Berhad continues to strengthen its presence in the Indonesian market, whilst establishing the Group’s efforts to intensify its position as a major international biopharmaceutical    [ see more ]

PHARMANIAGA EMBRACING CAUTIOUSLY BUSINESS PROSPECTS IN FY2022 AMIDST THE UNCERTAIN GLOBAL MARKET

19 MAY 2022

Malaysia’s leading pharmaceutical company, Pharmaniaga Berhad (Pharmaniaga) continues to record growth during the first quarter ended 31 March 2022 (Q1FY2022) despite the    [ see more ]

REPORTS

View our latest news and media releases, access our photo and video gallery, our CURE magazine as well as download our Annual and Sustainability Reports.

MEDIA ENQUIRIES

Please contact:

Dato’ Zuhri Iskandar Kamarzaman
Deputy Director
Corporate Services

+603-3342 9999 ext 434
+603-3342 6629
zuhri@pharmaniaga.com
Pharmaniaga Berhad

No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, 40000 Shah Alam, Selangor, MALAYSIA